Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurofibromin in the brain.

David H Gutmann1

  • 1Department of Neurology, Washington University School of Medicine, and The Neurofibromatosis Program, St. Louis Children's Hospital, MO 63110, USA. gutmannd@neuro.wustl.edu

Journal of Child Neurology
|October 31, 2002
PubMed
Summary

Neurofibromatosis 1 (NF1) causes brain abnormalities in astrocytes and neurons due to reduced neurofibromin. Understanding NF1

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nested pediatric low-grade glioma cerebral organoid avatars reveal glutamatergic neuron stromal growth dependency.

Genes & development·2026
Same author

Differences in Optic Pathway Glioma Prevalence Among Children with Neurofibromatosis Type 1.

The Journal of pediatrics·2026
Same author

Central Precocious Puberty and Optic Pathway Glioma in Children with Neurofibromatosis 1: Associations with Tumor Location, Vision, and Treatment.

The Journal of pediatrics·2026
Same author

Nested ecosystems theory for conceptualizing brain tumors.

Disease models & mechanisms·2026
Same author

Time trends in the male to female ratio for autism incidence: population based, prospectively collected, birth cohort study.

BMJ (Clinical research ed.)·2026
Same author

Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation.

Neuro-oncology advances·2026

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Neurofibromatosis 1 (NF1) is a common autosomal dominant disorder impacting the nervous system.
  • NF1 is characterized by abnormalities in astrocytes and neurons, stemming from reduced or absent expression of the NF1 gene product, neurofibromin.
  • Impaired neurofibromin function contributes to astrocytomas, learning disabilities, and brain abnormalities in individuals with NF1.

Purpose of the Study:

  • To explore the molecular pathogenesis of neurofibromatosis 1-associated brain abnormalities.
  • To highlight advances in understanding the role of NF1 in central nervous system development.
  • To lay the groundwork for future targeted therapies for NF1-related brain conditions.

Main Methods:

  • Review of current research on NF1 gene function and its impact on neural cells.
  • Analysis of molecular mechanisms underlying neurofibromin deficiency.
  • Correlation of genetic factors with observed neurological and radiological phenotypes.

Main Results:

  • Identification of NF1 as a key factor in the development of brain abnormalities.
  • Elucidation of the link between neurofibromin dysfunction and cellular abnormalities in astrocytes and neurons.
  • Advances in understanding the molecular basis of NF1-associated learning disabilities and brain malformations.

Conclusions:

  • The identification of NF1 has significantly advanced the understanding of its associated molecular pathogenesis.
  • Continued research into NF1 function is crucial for developing effective treatments.
  • Future therapeutic strategies can be developed based on a deeper comprehension of NF1's role in the central nervous system.

Related Experiment Videos